QUOTIENT SCIENCES
Updates & Highlights
Quotient Sciences advances AI-designed drug product into Phase I clinical study
Quotient Sciences advances AI-designed drug product into Phase I clinical study
Indian Pharma Post · 11 days ago
Quotient Sciences Advances AI-Designed Drug Product into Clinical Development
Quotient Sciences Advances AI-Designed Drug Product into Clinical Development
PR Newswire · 11 days ago
Quotient Sciences advances AI-designed drug product into Phase I clinical study
Quotient Sciences advances AI-designed drug product into Phase I clinical study
Indian Pharma Post · 12 days ago
Recent Openings
View all 1 jobsCulture & Mission
Benefits & Perks
Learning Budget
Professional development
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Quotient Sciences?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company →News & Press
17 recentQuotient Sciences advances AI-designed drug product into Phase I clinical study
Quotient Sciences advances AI-designed drug product into Phase I clinical study
Indian Pharma Post · 11 days ago
Quotient Sciences Advances AI-Designed Drug Product into Clinical Development
Quotient Sciences Advances AI-Designed Drug Product into Clinical Development
PR Newswire · 11 days ago
Quotient Sciences advances AI-designed drug product into Phase I clinical study
Quotient Sciences advances AI-designed drug product into Phase I clinical study
Indian Pharma Post · 12 days ago
Quotient Sciences Extends Partnership with Ipsen for Manufacture of Ultra-Rare Disease Treatment
Quotient Sciences Extends Partnership with Ipsen for Manufacture of Ultra-Rare Disease Treatment
PharmTech.com · 3 months ago
Quotient Sciences, Ipsen Extend Commercial Manufacturing Pact
Quotient Sciences, Ipsen Extend Commercial Manufacturing Pact
Contract Pharma · 3 months ago
Lindus Health, Quotient Sciences Partner to Accelerate Drug Development to Clinical Trials
Lindus Health, Quotient Sciences Partner to Accelerate Drug Development to Clinical Trials
Contract Pharma · 6 months ago
Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
PharmaTimes · 6 months ago
Lindus Health and Quotient Sciences to support sponsors with trial recruitment
Lindus Health and Quotient Sciences to support sponsors with trial recruitment
Clinical Trials Arena · 6 months ago
Lindus Health and Quotient Sciences Partner to Accelerate Drug Development from First-in-Human to Pivotal Trials
Lindus Health and Quotient Sciences Partner to Accelerate Drug Development from First-in-Human to Pivotal Trials
PR Newswire · 6 months ago
Quotient Sciences, Intrepid Labs Partner to Advance AI in Early Drug Development
Quotient Sciences, Intrepid Labs Partner to Advance AI in Early Drug Development
Contract Pharma · 6 months ago
Quotient Sciences, Biorasi form partnership for early phase trials
Quotient Sciences, Biorasi form partnership for early phase trials
Clinical Trials Arena · 8 months ago
Quotient Sciences and Biorasi partner to accelerate early phase clinical trials to patient proof-of-concept
Quotient Sciences and Biorasi partner to accelerate early phase clinical trials to patient proof-of-concept
PR Newswire · 8 months ago
Drug Development Firm Quotient Sciences Faces Market Pressures
Drug Development Firm Quotient Sciences Faces Market Pressures
Manufacturing Management · 8 months ago
Quotient Sciences and CPI Partner to Enhance RNA Therapy Development and Production Efficiency
Quotient Sciences and CPI Partner to Enhance RNA Therapy Development and Production Efficiency
geneonline.com · 9 months ago
Quotient Sciences and CPI to expedite RNA therapy development
Quotient Sciences and CPI to expedite RNA therapy development
Pharmaceutical Technology · 9 months ago
Quotient Sciences, CPI Form RNA Drug Development Joint Venture
Quotient Sciences, CPI Form RNA Drug Development Joint Venture
Contract Pharma · 9 months ago
Quotient Sciences expands UK plant - BioProcess Insider
Quotient Sciences expands UK plant - BioProcess Insider
BioProcess International · over 2 years ago